Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

MAB8616

Sigma-Aldrich

Anti-Varicella-Zoster Virus Antibody, Immediate Early Gene 62

Chemicon®, from mouse

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Code UNSPSC :
12352203
eCl@ss :
32160702
Nomenclature NACRES :
NA.41

Source biologique

mouse

Niveau de qualité

300

Forme d'anticorps

purified immunoglobulin

Type de produit anticorps

primary antibodies

Clone

monoclonal

Espèces réactives

human

Fabricant/nom de marque

Chemicon®

Technique(s)

immunofluorescence: suitable
immunohistochemistry: suitable
immunoprecipitation (IP): suitable
western blot: suitable

Isotype

IgG1

Conditions d'expédition

wet ice

Spécificité

Recognizes the VZV immediate early gene 62. No cross-reactivity to HSV.

Immunogène

Epitope: Immediate Early Gene 62
VZV HZ strain.

Application

Indirect immunofluorescence: shows a nuclear and cytoplasmic staining pattern.

Immunoprecipitation

Western blotting

Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Varicella-Zoster Virus Antibody, Immediate Early Gene 62 is validated for use in IF, IP, WB, IH for the detection of Varicella-Zoster Virus.

Forme physique

Format: Purified
Purified immunoglobulin. In 0.02M PB with 0.25M NaCl, pH=7.6 with 0.1% Sodium azide.

Stockage et stabilité

Maintain at 2-8°C for up to 12 months.

Autres remarques

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Informations légales

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Vous ne trouvez pas le bon produit ?  

Essayez notre Outil de sélection de produits.

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Immunohistochemical detection of intra-neuronal VZV proteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens.
Werner J D Ouwendijk,Sarah E Flowerdew,Desiree Wick,Anja K E Horn,Inga Sinicina et al.
Journal of Neurovirology null
Stefan L Oliver et al.
Journal of virology, 91(1) (2016-11-01)
The highly conserved herpesvirus glycoprotein complex gB/gH-gL mediates membrane fusion during virion entry and cell-cell fusion. Varicella-zoster virus (VZV) characteristically forms multinucleated cells, or syncytia, during the infection of human tissues, but little is known about this process. The cytoplasmic
Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.
Suenaga T, Satoh T, Somboonthum P, Kawaguchi Y, Mori Y, Arase H
Proceedings of the National Academy of Sciences of the USA null
Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies.
Wang, GQ; Suzutani, T; Yamamoto, Y; Fukui, Y; Nozawa, N; Schmid, DS; Kurane, I; Inoue, N
Antimicrobial agents and chemotherapy null
Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.
Naoki Inoue,Misato Matsushita,Yoshiko Fukui,Souichi Yamada,Mihoko Tsuda,Chizuka Higashi et al.
Journal of virology null
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique